アステラス薬(4503) ENZALUTAMIDE PHASE 2 TERRAIN TRIAL DEMONSTRATED STATISTICALLY SIGNIFICANT INCREASE IN PFS AS COMPARED TO BICALUTAMIDE IN METASTATIC PROSTATE CANCER
2015/01/23
ブックマーク
メモを書く
/
-
読み込み中…